Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

NCT04304508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1808

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Non-cardioembolic Ischemic Stroke

Interventions

DRUG: BAY2433334
OTHER: BAY2433334 matching placebo

Sponsor

Bayer

Collaborators

[object Object]